Longterm Follow-up After Remote Ischemic Preconditioning for Prevention of Contrast-induced Nephropathy

University of Cologne81 enrolled

Overview

Remote ischemic preconditioning reduces the incidence of contrast-induced acute kidney injury in patients undergoing elective coronary angiography. This study was designed to acquire long-term data of initially randomized patients in the RenPro Trial.

Data of the RenPro Trial has been already published. In the present study data of longterm follow up are collected.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Impaired Renal Function

Interventions

Ischemic preconditioningOTHER

Subjects received ischemic preconditioning previous to cardiac catheterization

Eligibility

Sex: ALLMin age: 18 YearsMax age: 90 Years

Medical Language ↔ Plain English

All patients who participated to the RenPro trial

Locations (1)

University of Cologne

Cologne, North Rhine-Westphalia, Germany

Outcomes

Primary Outcomes

MACCE

Major Adverse Cardiac and Cerebrovascular Events (Combined primary endpoint): All-cause mortality, cardiovascular mortality, rehospitalization, stroke, myocardial infarction, hemodialysis

Time frame: 1 Year

Secondary Outcomes

Renal function

changes of serum creatinine, eGFR, NGAL and cystatin C compared to baseline in both groups.

Time frame: 1 year

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.